Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Safety, tolerability and immunogenicity of a novel 24-valent pneumococcal vaccine in toddlers: A phase 1 randomized controlled trial.
Journal: Vaccine
Published: October 05, 2023
Phase 1/2 study of a novel 24-valent pneumococcal vaccine in healthy adults aged 18 to 64 years and in older adults aged 65 to 85 years.
Journal: Vaccine
Published: February 04, 2022
Evaluation of the Safety, Tolerability and Immunogenicity of ShigETEC, an Oral Live Attenuated Shigella-ETEC Vaccine in Placebo-Controlled Randomized Phase 1 Trial.
Journal: Vaccines
Published: January 01, 2022
Characterization of ShigETEC, a Novel Live Attenuated Combined Vaccine against Shigellae and ETEC.
Journal: Vaccines
Published: October 15, 2020
Engineered PRINT(®) nanoparticles for controlled delivery of antigens and immunostimulants.
Journal: Human vaccines & immunotherapeutics
Published: November 27, 2014
The nanomedicines alliance: an industry perspective on nanomedicines.
Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: June 09, 2014
US Military contributions to the global response to pandemic chikungunya.
Journal: Vaccine
Published: June 19, 2012
Development of a nanoparticle-based influenza vaccine using the PRINT technology.
Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: June 11, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026